IRVINE, Calif., Aug. 16, 2005 (PRIMEZONE) -- The Korea Times and the U.S.-based weekly Science are reporting that a Korean husband-and-wife scientist team has had a breakthrough in adult stem cell research with the discovery of a gene in charge of differentiating the parent cells in human bodies.
"They're reporting that they've found a gene that modulates all the factors in differentiating an adult stem cell," stated SmallCap Sentinel analyst, D.R. Clark. "This is extremely significant, hence the 'Holy Grail' exuberance. Previously, only genes that modified some of the factors had been discovered. This could open significant doors.
"It's also interesting to note that this discovery was accomplished through a joint effort of M.I.T. and Harvard," added Clark.
An informational report titled "Looking at the Political Impact on Stem Cell Research" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com.
New Life Scientific (OTCBB:NWLF), which endeavors to blend Eastern European research and development with Western management, Genentech, Inc. (NYSE:DNA), Sepracor Inc. (Nasdaq:SEPR), and Celgene Corporation (Nasdaq:CELG) will be discussed in the report.
Individuals may also register to receive free future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid thirty-six hundred dollars for preparation and distribution of this report and other advertising services by Emerging Markets Consulting LLC. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.